Abstract:Abstract Background Interleukin-15 (IL-15) is a critical cytokine for the development, proliferation, and function of natural killer (NK) cells, NKT cells, and CD8 + memory T cells and has become one of the most promising protein molecules for the treatment of cancer and viral diseases. However, there are several limitations in applying IL-15 in therapy, such as its low yield in vitro, limited potency, and short half-life in vivo. To date, there are several recombinant IL-15 agonists based on configurational modifications that are being pursued in the treatment of cancer, such as ALT-803, which are mainly produced from mammalian cells. Results In this study, we designed two different forms of the IL-15 complex, which were formed by the noncovalent assembly of IL-15 with dimeric or monomeric sushi domain of IL-15 receptor α (SuIL-15Rα)-IgG4 Fc fusion protein and designated IL-15/SuIL-15Rα-dFc and IL-15/SuIL-15Rα-mFc, respectively. The two IL-15 complexes were expressed in Pichia pastoris ( P. pastoris ), and their activities and half-lives were evaluated and compared. Pharmacokinetic analysis showed that IL-15/SuIL-15Rα-dFc had a half-life of 14.26 h while IL-15/SuIL-15Rα-mFc had a half-life of 9.16 h in mice, which were much longer than the 0.7-h half-life of commercial recombinant human IL-15 (rhIL-15). Treatment of mice with intravenous injection of the two IL-15 complexes resulted in significant increases in NK cells, NKT cells, and memory CD8 + T cells, which were not observed after rhIL-15 treatment. Treatment of human peripheral blood mononuclear cells (PBMCs) from healthy donors with the two IL-15 complexes yielded enhanced NK and CD8 + T cell activation and proliferation, which was comparable to the effect of rhIL-15. Conclusions These findings indicate that the IL-15/SuIL-15Rα-dFc and IL-15/SuIL-15Rα-mFc produced in P. pastoris exhibit potent activities and prolonged half-lives and may serve as superagonists for immunotherapy in further research and applications.

Codon Optimization, Expression, Purification, and Functional Characterization of Recombinant Human IL-25 in Pichia Pastoris

Expression and Purification of Recombinant Human Interleukin-11 in Pichia Pastoris

Expression of Recombinant Human Interleukin-13 in Pichia Pastoris and Its Bioactivity in Vitro

Expression, Purification, and Polyethylene Glycol Site-Specific Modification of Recombinant Human Interleukin 24 in Escherichia coli

Soluble expression, rapid purification, and characterization of human interleukin-24 (IL-24) using a MBP-SUMO dual fusion system in Escherichia coli

Preparation of Recombinant Human IL-17A and IL-17F and Determination of Their Bioactivities

Expression, purification, and biological characterization of recombinant human interleukin-31 protein

Recombinant human interleukin 15 long peptide fragment and production method thereof

Purification and Characterization of Non-Fusion Recombinant Human Interleukin-18 Expressed in E. Coli

Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives

The Effect of Gene Copy Number and Co-Expression of Chaperone on Production of Albumin Fusion Proteins in Pichia Pastoris.

Utilization of SUMO Expressing Vector to Express Human Interleukin-17 and Studying of Its Bioactivity

[Prokaryotic expression, purification, refolding and biological assays of recombinant human interleukin 4 inclusion body]

Study on the Expression and Immune Enhancement of IL-18-GPI Fused Protein

SUMO-fusion and autoinduction-based combinatorial approach for enhanced production of bioactive human interleukin-24 in Escherichia coli

Expression, refolding and purification of a human interleukin-17A variant

Expression and Purification of Hybrid LL-37Tα1 Peptide in Pichia pastoris and Evaluation of Its Immunomodulatory and Anti-inflammatory Activities by LPS Neutralization

Efficient plant-based production of chicken interleukin-12 yields a strong immunostimulatory cytokine

Soluble Expression and Purification of Recombinant Human Interleukin-21 in Escherichia Coli

A combinatorial approach of N-terminus blocking and codon optimization strategies to enhance the soluble expression of recombinant hIL-7 in E. coli fed-batch culture

[Purification of Fusion Protein HSA/IL1ra and Its Bioactivity].